相关实验视频

Updated: Jun 9, 2026

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
14:04

Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents

Published on: March 25, 2016

15.2K

针对复发性/耐药性B细胞急性淋巴细胞白血病和地幔细胞淋巴瘤的brexu-cel的成本效益研究:系统性审查

Asmita Priyadarshini Khatiwada1, Ahmed Mostafa Ahmed Kamel1, Nathorn Chaiyakunapruk2

  • 1Health Outcomes Research and Policy, Harrison College of Pharmacy, Auburn University, Auburn, AL, USA.

Expert review of pharmacoeconomics & outcomes research
|December 5, 2024
PubMed
概括

在一些地区,Brexu-cel在复发性/耐药性急性淋巴细胞白血病 (R/R ALL) 和地幔细胞淋巴瘤 (R/R MCL) 中表现出成本效益. 然而,其他医疗技术评估机构报告其价值存在不确定性.

关键词:
布雷克苏卡巴泰基因自动化细胞在HTA报告中,HTA报告.这就是BREXU-CEL.经济效益性 经济效益性系统性审查 系统性审查

更多相关视频

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K
Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

3.3K

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...